Your browser doesn't support javascript.
loading
Low-dose rituximab every 6 months for the treatment of acetylcholine receptor-positive refractory generalized myasthenia gravis.
Lu, Jun; Zhong, Huahua; Jing, Sisi; Wang, Liang; Xi, Jianying; Lu, Jiahong; Zhou, Lei; Zhao, Chongbo.
Afiliación
  • Lu J; Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
  • Zhong H; Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
  • Jing S; Department of Neurology, Jing'an District Centre Hospital of Shanghai, Fudan University, Shanghai, China.
  • Wang L; Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
  • Xi J; Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
  • Lu J; Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
  • Zhou L; Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
  • Zhao C; Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
Muscle Nerve ; 61(3): 311-315, 2020 03.
Article en En | MEDLINE | ID: mdl-31875994
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rituximab / Factores Inmunológicos / Miastenia Gravis Tipo de estudio: Observational_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Muscle Nerve Año: 2020 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Rituximab / Factores Inmunológicos / Miastenia Gravis Tipo de estudio: Observational_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Muscle Nerve Año: 2020 Tipo del documento: Article País de afiliación: China